» Articles » PMID: 36979334

Somatic Cell Reprogramming for Nervous System Diseases: Techniques, Mechanisms, Potential Applications, and Challenges

Overview
Journal Brain Sci
Publisher MDPI
Date 2023 Mar 29
PMID 36979334
Authors
Affiliations
Soon will be listed here.
Abstract

Nervous system diseases present significant challenges to the neuroscience community due to ethical and practical constraints that limit access to appropriate research materials. Somatic cell reprogramming has been proposed as a novel way to obtain neurons. Various emerging techniques have been used to reprogram mature and differentiated cells into neurons. This review provides an overview of somatic cell reprogramming for neurological research and therapy, focusing on neural reprogramming and generating different neural cell types. We examine the mechanisms involved in reprogramming and the challenges that arise. We herein summarize cell reprogramming strategies to generate neurons, including transcription factors, small molecules, and microRNAs, with a focus on different types of cells.. While reprogramming somatic cells into neurons holds the potential for understanding neurological diseases and developing therapeutic applications, its limitations and risks must be carefully considered. Here, we highlight the potential benefits of somatic cell reprogramming for neurological disease research and therapy. This review contributes to the field by providing a comprehensive overview of the various techniques used to generate neurons by cellular reprogramming and discussing their potential applications.

Citing Articles

Study on the therapeutic potential of induced neural stem cells for Alzheimer's disease in mice.

Ji Q, Lv Y, Hu B, Su Y, Shaikh I, Zhu X Biol Res. 2024; 57(1):89.

PMID: 39582031 PMC: 11587668. DOI: 10.1186/s40659-024-00568-0.


From Young to Old: Mimicking Neuronal Aging in Directly Converted Neurons from Young Donors.

Varghese N, Grimm A, Cader M, Eckert A Cells. 2024; 13(15.

PMID: 39120291 PMC: 11311457. DOI: 10.3390/cells13151260.


A Decade of Dedication: Pioneering Perspectives on Neurological Diseases and Mental Illnesses.

Tanaka M, Vecsei L Biomedicines. 2024; 12(5).

PMID: 38791045 PMC: 11117868. DOI: 10.3390/biomedicines12051083.


Innovation at the Intersection: Emerging Translational Research in Neurology and Psychiatry.

Tanaka M, Battaglia S, Gimenez-Llort L, Chen C, Hepsomali P, Avenanti A Cells. 2024; 13(10.

PMID: 38786014 PMC: 11120114. DOI: 10.3390/cells13100790.


Neural Correlates and Molecular Mechanisms of Memory and Learning.

Battaglia S, Avenanti A, Vecsei L, Tanaka M Int J Mol Sci. 2024; 25(5).

PMID: 38473973 PMC: 10931689. DOI: 10.3390/ijms25052724.

References
1.
Olson J, Asakura A, Snider L, Hawkes R, Strand A, Stoeck J . NeuroD2 is necessary for development and survival of central nervous system neurons. Dev Biol. 2001; 234(1):174-87. DOI: 10.1006/dbio.2001.0245. View

2.
Prabhakaran D, Anand S, Watkins D, Gaziano T, Wu Y, Mbanya J . Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2017; 391(10126):1224-1236. PMC: 5996970. DOI: 10.1016/S0140-6736(17)32471-6. View

3.
Wan X, Xu L, Li B, Sun Q, Ji Q, Huang D . Chemical conversion of human lung fibroblasts into neuronal cells. Int J Mol Med. 2018; 41(3):1463-1468. PMC: 5819915. DOI: 10.3892/ijmm.2018.3375. View

4.
Yoo A, Sun A, Li L, Shcheglovitov A, Portmann T, Li Y . MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011; 476(7359):228-31. PMC: 3348862. DOI: 10.1038/nature10323. View

5.
Kim J, Efe J, Zhu S, Talantova M, Yuan X, Wang S . Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A. 2011; 108(19):7838-43. PMC: 3093517. DOI: 10.1073/pnas.1103113108. View